News
The latest news from HCCI

For general media inquiries or to propose collaborative projects, please contact us

Reuters: U.S. Insulin Costs Per Patient Nearly Doubled From 2012 to 2016: Study

​HCCI's latest research on rising insulin prices was recently featured in Reuters. HCCI's report detailed both use and price trends of insulin used by those with type 1 diabetes from 2012 to 2016. Per Reuters article:

"A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that at $2,864 per patient in 2012, according to a report due to be released on Tuesday by the nonprofit Health Care Cost Institute (HCCI).

The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.

The increasing cost of insulin has led some patients to put their own health at risk.

In recent months, anecdotal stories have cropped up from family members and patients describing the rationing of the life-saving medication because they could not afford out-of-pocket expenses for insulin. That has also led to some protests outside company headquarters of insulin makers."

...

U.S. insulin costs per patient nearly doubled from 2012 to 2016: study | Reuters

The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.' /